Browse All

Current Filters

CLEAR FILTER x

TITLE

Eligibility for the Donanemab Trial in a Population-Based Study of Cognitive Aging

Author:Jones, Katherine   Aakre, Jeremiah   Castillo, Anna   Ramanan, Vijay   Kremers, Walter   Jack, Clifford   Vemuri, Prashanthi   Lowe, Val   Knopman, David   Petersen, Ronald   Vassilaki, Maria   Graff-Radford, Jonathan   

Session Name:N4: Neuroscience in the Clinic: Alzheimer's Disease Biomarker Testing and Amyloid Monoclonals in Clinical Practice  

Topic:Aging, Dementia, Cognitive, and Behavioral Neurology  

Program Number:N4.001  

Author Institution:Mayo Clinic, Rochester, MN  

Neuroinflammation Co-localizes Highly with Tau in Mild Cognitive Impairment from Early Onset Alzheimer’s Disease

Author:Appleton, Johanna   Funk, Quentin   Zanotti Fregonara, Paolo   Yu, Meixiang   Faridar, Alirexa   Nakawah, Mohammad   Carrillo, Maria   Dickerson, Bradford   Rabinovici, Gil   Apostolova, Liana   Masdeu, Joseph   Pascual, Belen   

Session Name:N4: Neuroscience in the Clinic: Alzheimer's Disease Biomarker Testing and Amyloid Monoclonals in Clinical Practice  

Topic:Aging, Dementia, Cognitive, and Behavioral Neurology  

Program Number:N4.002  

Author Institution:Houston Methodist, Houston, TX  Molecular Imaging Branch, National Institute of Mental Health, Houston, TX  Methodist Neurological Institute, Houston, TX  Houston Methodist Hospital, Houston, TX  Alzheimer's Association, Chicago, IL  Massachusetts General Hospital, Charlestown, MA  UCSF Memory & Aging Center, San Francisco, CA  Indiana University School of Medicine, Indianapolis, IN  Houston Methodist Neurological Institute, Houston, TX  

Effect of cerebrovascular risk factors on the prediction of Alzheimer’s disease neuropathologic change using plasma biomarkers

Author:Bermudez, Camilo   Syrjanen, Jeremy   Petersen, Ronald   Knopman, David   Ramanan, Vijay   Jack, Clifford   Nguyen, Aivi   Reichard, Ross   Kouri, Naomi   Moloney, Christina   Algeciras-Schimnich, Alicia   Murray, Melissa   Mielke, Michelle   Vemuri, Prashanthi   Graff-Radford, Jonathan   

Session Name:N4: Neuroscience in the Clinic: Alzheimer's Disease Biomarker Testing and Amyloid Monoclonals in Clinical Practice  

Topic:Aging, Dementia, Cognitive, and Behavioral Neurology  

Program Number:N4.003  

Author Institution:Mayo Clinic, Rochester, MN  Mayo Clinic, Jacksonville, FL  Wake Forest University School of Medicine, Winston-Salem, NC  

CSF levels of proinflammatory and anti-inflammatory cytokines as predictors of cognitive decline across Alzheimer’s disease spectrum

Author:Petersen, Kellen   Nallapu, Bhargav   Lipton, Richard   Ezzati, Ali   

Session Name:N4: Neuroscience in the Clinic: Alzheimer's Disease Biomarker Testing and Amyloid Monoclonals in Clinical Practice  

Topic:Aging, Dementia, Cognitive, and Behavioral Neurology  

Program Number:N4.004  

Author Institution:Albert Einstein College of Medicine, Bronx, NY  University of California, Irvine, Irvine, CA